Recent advances in molecular biology have led to the identification of a FIP1L1-PDGFRA fusion gene as a recurrent abnormality in some patients with HES.     ///    [Efficacy of imatinib in FIP1L1-PDGFRA positive hypereosinophilic syndrome].. 